🔗 Share this article

An underground market for unapproved slimming medications is propelled by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Investigational Treatment Acquiring Traction Online

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its supposed fat-burning properties. Followers are urged to contact these profiles privately for source information, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Separately, a robust market exists on Telegram, where groups with thousands of participants share comparison images, administration instructions and assertions of next-day British shipping. Sellers market the substance there before directing customers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Experts Voice Concerns

Nevertheless, physicians and pharmacists have warned that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to users administering products of unknown origin.

Some professionals stated the demand for retatrutide could be linked to the increasing price of approved slimming products such as Mounjaro.

Regulatory Status and Implementation

Marketing the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be promoted or distributed for human use under the British medical regulations.

Some influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate pharmaceutical, advertising, and consumer regulations, risking fines, prosecution or prison.

Service Reaction and Content Elimination

Based on the social media company, the service has removed problematic material and banned associated keywords and query recommendations. The company stated it was committed to keeping the service safe and investing in enhancing enforcement strategies.

Digital Marketplace Activities

Research also found groups with up to nine thousand participants marketing the experimental drug using Telegram's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately displays channels with thousands of users, filled with photos of weight loss, glowing testimonials and detailed instructions for mixing or administering at residence.

Within minutes of joining one group, a seller shared contact information, where the majority of transactions occur. The seller provided an instruction manual and promised shipping within 48 hours. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a image of a alleged testing documentation. None inquired about body mass, health issues or past usage.

Product Information and Pricing

Within these groups, messages display dark colored parcels with Royal Mail stickers, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at residence with purified liquid, or ready-to-use injectors typically sold at 160 pounds for 20 milligrams. When asked how long a injector should be used, vendors give contradictory answers ranging from a several days to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for Telegram said it actively moderated dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting substances they cannot confirm. Even if the research behind this drug is sound, these online products may not include what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the surge in demand to current cost increases for authorized slimming medications such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake treatments are highly risky. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she explained.

Her team has previously seen patients injured by personal administration from unverified suppliers. “We understand the disappointment, but purchasing from Telegram or communication platforms is taking chances with your well-being,” stated the doctor. “These materials could be contaminated or improperly measured.”

Producer Statement

A representative from Eli Lilly said the substance was in third stage research studies and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this point no one can market [it] for human use,” they explained, noting that any item “falsely representing itself as a Lilly investigational product not yet authorized … may expose patients to possibly significant medical dangers”.